Nicholas Gross

Nicholas Gross

Director, Commercial Strategy

Nicholas has almost a decade of biopharma experience in various commercial roles including commercial strategy, new product planning, market access, and brand marketing. During his tenure in the industry, he has worked across several therapeutic areas including cardiovascular disease.

Prior to joining InCarda, Nicholas served as the commercial strategy lead at Dompé US, a private company developing and commercializing innovative treatments for rare ophthalmic diseases. He also spent 7 years at Amgen launching and commercializing products, primarily in cardiovascular and oncology disease areas.

Nicholas holds a BA in Sociology from Yale University, and an MBA concentrated in Marketing and Strategy from the University of Virginia, Darden School of Business.

For more information about InCarda: